Literature DB >> 29410304

Life after per-oral endoscopic myotomy: long-term outcomes of quality of life and their association with Eckardt scores.

Yaseen B Perbtani1, Lazarus K Mramba2, Dennis Yang1, Jorge Suarez1, Peter V Draganov1.   

Abstract

BACKGROUND AND AIMS: The clinical efficacy of per-oral endoscopic myotomy (POEM) has been commonly established by reduction in the Eckardt score (<3) after the procedure. However, achalasia can lead to significant impairment in the patient's quality of life that may go beyond the 4 classic achalasia symptoms as measured by the Eckardt score. The aims of our study were to evaluate the effect of POEM on short-term and long-term health-related quality of life (HRQOL) and to assess the association between HRQOL and Eckardt scores.
METHODS: Single-center, prospective, cohort study of consecutive POEMs during a 3-year period. Eckardt and HRQOL scores as measured by the short-form survey questionnaire (SF-36) were obtained at baseline and at various intervals after POEM. Comparison of the mean scores was described by using univariate linear regression. The association between Eckardt scores and HRQOL were calculated by using a linear, mixed-model analysis.
RESULTS: POEM was performed in 143 consecutive patients (54% male; mean ± standard deviation [SD] age, 56.9 ± 17.9 years). At long-term follow-up (mean 16.4 months, range 12-40), both the HRQOL baseline mental and physical component scores improved significantly from 61.5 ± 2.2 to 71.2 ± 3.6; (P < .021) and from 55.8 ± 2.2 to 63.6 ± 3.3; (P = < .034), respectively. Mixed-model analysis showed a significant association between Eckardt and all HRQOL scores (P < .001).
CONCLUSION: POEM improved all dimensions of HRQOL as measured by the SF-36 survey at both short-term and long-term follow-up. A strong association was seen between Eckardt scores and all HRQOL domains. Further studies with the use of disease-specific HRQOL instruments are warranted. (Clinical trial registration number: NCT01832779.).
Copyright © 2018 American Society for Gastrointestinal Endoscopy. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29410304     DOI: 10.1016/j.gie.2018.01.019

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  8 in total

Review 1.  Peroral endoscopic myotomy (POEM) for achalasia.

Authors:  Yahya Ahmed; Mohamed O Othman
Journal:  J Thorac Dis       Date:  2019-08       Impact factor: 2.895

Review 2.  Esophageal Third Space Endoscopy: Recent Advances.

Authors:  Malav P Parikh; Niyati M Gupta; Madhusudhan R Sanaka
Journal:  Curr Treat Options Gastroenterol       Date:  2019-03

3.  Development of quality indicators for the diagnosis and management of achalasia.

Authors:  Afrin N Kamal; Priya Kathpalia; Fouad Otaki; Albert J Bredenoord; Donald O Castell; John O Clarke; Gary W Falk; Ronnie Fass; C Prakash Gyawali; Peter J Kahrilas; Philip O Katz; David A Katzka; John E Pandolfino; Roberto Penagini; Joel E Richter; Sabine Roman; Edoardo Savarino; George Triadafilopoulos; Michael F Vaezi; Marcelo F Vela; David A Leiman
Journal:  Neurogastroenterol Motil       Date:  2021-03-15       Impact factor: 3.960

4.  Quality of Life Following Peroral Endoscopic Myotomy for Esophageal Achalasia: A Systematic Review and Meta-Analysis.

Authors:  Chunyu Zhong; Shali Tan; Yutang Ren; Muhan Lü; Yan Peng; Xiangsheng Fu; Xiaowei Tang
Journal:  Ann Thorac Cardiovasc Surg       Date:  2020-03-04       Impact factor: 1.520

5.  Prospective evaluation of the efficacy of peroral endoscopic myotomy in patients with achalasia.

Authors:  Eun Jeong Gong; Hee Kyong Na; Ji Yong Ahn; Kee Wook Jung; Do Hoon Kim; Kee Don Choi; Ho June Song; Hwoon-Yong Jung
Journal:  Medicine (Baltimore)       Date:  2021-06-11       Impact factor: 1.817

6.  Peroral endoscopic myotomy is effective and safe in non-achalasia esophageal motility disorders: an international multicenter study.

Authors:  Mouen A Khashab; Pietro Familiari; Peter V Draganov; Hanaa Dakour Aridi; Joo Young Cho; Michael Ujiki; Ricardo Rio Tinto; Hubert Louis; Pankaj N Desai; Vic Velanovich; Eduardo Albéniz; Amyn Haji; Jeffrey Marks; Guido Costamagna; Jacques Devière; Yaseen Perbtani; Mason Hedberg; Fermin Estremera; Luis A Martin Del Campo; Dennis Yang; Majidah Bukhari; Olaya Brewer; Omid Sanaei; Lea Fayad; Amol Agarwal; Vivek Kumbhari; Yen-I Chen
Journal:  Endosc Int Open       Date:  2018-08-10

7.  Effect and safety of mark-guided vs standard peroral endoscopic myotomy: A retrospective case control study.

Authors:  De-Feng Li; Feng Xiong; Zhi-Chao Yu; Hai-Yang Zhang; Ting-Ting Liu; Yan-Hui Tian; Rui-Yue Shi; Ming-Guang Lai; Yang Song; Zheng-Lei Xu; Ding-Guo Zhang; Jun Yao; Li-Sheng Wang
Journal:  World J Gastroenterol       Date:  2020-03-07       Impact factor: 5.742

Review 8.  Peroral Endoscopic Myotomy as a Novel Treatment for Achalasia: Patient Selection and Perspectives.

Authors:  Pravallika Chadalavada; Prashanthi N Thota; Siva Raja; Madhusudhan R Sanaka
Journal:  Clin Exp Gastroenterol       Date:  2020-11-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.